MSLE
Satellos Bioscience Inc. Common Stock
NASDAQ: MSLE · HEALTHCARE · BIOTECHNOLOGY
$7.27
-4.47% today
Updated 2026-04-29
Market cap
$149.15M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.70
Dividend yield
—
52W range
$5 – $13
Volume
0.1M
Satellos Bioscience Inc. Common Stock (MSLE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-3.95M | $-4.26M | $-8.73M | $-17.40M | $-23.60M |
| Capital expenditures | $5683.00 | $2210.00 | $13568.00 | $4180.00 | $6000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $761973.00 | $1.06M | $1.64M | $1.47M | $3.23M |
| Free cash flow | $-3.95M | $-4.26M | $-8.75M | $-17.41M | $-23.60M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | $0.00 | $0.00 | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |